HCC cell-derived EVs inhibit tumor growth by transferring HCC antigens and antigenic chaperones to DCs, which induces cytolysis and increases IFN-γ expression but decreases IL-10 and TGF-β expression. The gene discussed is IL10; the disease is neoplasm.